2019 Q4 Form 10-Q Financial Statement
#000156459020004619 Filed on February 13, 2020
Income Statement
| Concept | 2019 Q4 | 2018 Q4 |
|---|---|---|
| Revenue | $12.81M | $14.22M |
| YoY Change | -9.97% | 2.49% |
| Cost Of Revenue | $5.097M | $9.172M |
| YoY Change | -44.43% | 1285.5% |
| Gross Profit | $7.708M | $13.19M |
| YoY Change | -41.54% | -0.23% |
| Gross Profit Margin | 60.2% | 92.71% |
| Selling, General & Admin | $6.083M | $11.36M |
| YoY Change | -46.47% | 168.02% |
| % of Gross Profit | 78.92% | 86.18% |
| Research & Development | ||
| YoY Change | ||
| % of Gross Profit | ||
| Depreciation & Amortization | $350.0K | $689.0K |
| YoY Change | -49.2% | 146.07% |
| % of Gross Profit | 4.54% | 5.23% |
| Operating Expenses | $7.427M | $14.05M |
| YoY Change | -47.12% | 226.65% |
| Operating Profit | $281.0K | -$134.0K |
| YoY Change | -309.7% | 67.5% |
| Interest Expense | $4.000K | $60.00K |
| YoY Change | -93.33% | -49.58% |
| % of Operating Profit | 1.42% | |
| Other Income/Expense, Net | ||
| YoY Change | ||
| Pretax Income | $203.0K | $258.0K |
| YoY Change | -21.32% | -48.71% |
| Income Tax | $0.00 | $0.00 |
| % Of Pretax Income | 0.0% | 0.0% |
| Net Earnings | -$42.00K | $305.0K |
| YoY Change | -113.77% | -57.99% |
| Net Earnings / Revenue | -0.33% | 2.14% |
| Basic Earnings Per Share | -$0.01 | $0.04 |
| Diluted Earnings Per Share | -$0.01 | $0.04 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 6.986M | 7.271M |
| Diluted Shares Outstanding | 6.992M | 7.278M |
Balance Sheet
| Concept | 2019 Q4 | 2018 Q4 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $4.607M | $3.326M |
| YoY Change | 38.51% | 10.87% |
| Cash & Equivalents | $4.607M | $3.326M |
| Short-Term Investments | ||
| Other Short-Term Assets | $2.094M | $2.407M |
| YoY Change | -13.0% | -41.29% |
| Inventory | $2.056M | $1.953M |
| Prepaid Expenses | ||
| Receivables | $5.627M | $5.508M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $14.38M | $13.19M |
| YoY Change | 9.02% | -15.02% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $6.606M | $10.00M |
| YoY Change | -33.96% | -5.18% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | $1.412M | |
| YoY Change | -7.65% | |
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $385.0K | $812.0K |
| YoY Change | -52.59% | 7.12% |
| Total Long-Term Assets | $8.439M | $12.53M |
| YoY Change | -32.66% | -4.57% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $14.38M | $13.19M |
| Total Long-Term Assets | $8.439M | $12.53M |
| Total Assets | $22.82M | $25.73M |
| YoY Change | -11.28% | -10.23% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $1.647M | $1.526M |
| YoY Change | 7.93% | -13.54% |
| Accrued Expenses | $4.466M | $642.0K |
| YoY Change | 595.64% | 109.12% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $327.0K | $292.0K |
| YoY Change | 11.99% | 11.03% |
| Total Short-Term Liabilities | $6.440M | $5.678M |
| YoY Change | 13.42% | 4.41% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $110.0K | $2.815M |
| YoY Change | -96.09% | -3.89% |
| Other Long-Term Liabilities | $1.511M | $221.0K |
| YoY Change | 583.71% | -14.34% |
| Total Long-Term Liabilities | $1.621M | $3.815M |
| YoY Change | -57.51% | -5.0% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $6.440M | $5.678M |
| Total Long-Term Liabilities | $1.621M | $3.815M |
| Total Liabilities | $8.061M | $9.493M |
| YoY Change | -15.08% | 0.41% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | $2.168M | |
| YoY Change | -54.69% | |
| Common Stock | $14.24M | |
| YoY Change | -3.42% | |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $14.76M | $16.23M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $22.82M | $25.73M |
| YoY Change | -11.28% | -10.23% |
Cashflow Statement
| Concept | 2019 Q4 | 2018 Q4 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$42.00K | $305.0K |
| YoY Change | -113.77% | -57.99% |
| Depreciation, Depletion And Amortization | $350.0K | $689.0K |
| YoY Change | -49.2% | 146.07% |
| Cash From Operating Activities | -$348.0K | -$314.0K |
| YoY Change | 10.83% | -885.0% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $297.0K | $232.0K |
| YoY Change | 28.02% | -40.21% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $203.0K | $935.0K |
| YoY Change | -78.29% | |
| Cash From Investing Activities | -$94.00K | $697.0K |
| YoY Change | -113.49% | -278.72% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | -2.621M | -450.0K |
| YoY Change | 482.44% | -93.17% |
| NET CHANGE | ||
| Cash From Operating Activities | -348.0K | -314.0K |
| Cash From Investing Activities | -94.00K | 697.0K |
| Cash From Financing Activities | -2.621M | -450.0K |
| Net Change In Cash | -3.063M | -67.00K |
| YoY Change | 4471.64% | -99.03% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$348.0K | -$314.0K |
| Capital Expenditures | $297.0K | $232.0K |
| Free Cash Flow | -$645.0K | -$546.0K |
| YoY Change | 18.13% | 56.9% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2018Q4 | us-gaap |
Supplies Expense
SuppliesExpense
|
324000 | |
| CY2019Q4 | us-gaap |
Interest Expense
InterestExpense
|
4000 | |
| CY2018Q4 | us-gaap |
Interest Expense
InterestExpense
|
60000 | |
| us-gaap |
Interest Expense
InterestExpense
|
34000 | ||
| us-gaap |
Interest Expense
InterestExpense
|
121000 | ||
| us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
-47000 | ||
| CY2019Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-42000 | |
| CY2018Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
305000 | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-303000 | ||
| us-gaap |
Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
|
558000 | ||
| us-gaap |
Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
|
937000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
10000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
243000 | ||
| us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
2698000 | ||
| us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
138000 | ||
| us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
4000 | ||
| us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
379000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-2702000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-517000 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-3135000 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-130000 | ||
| CY2019Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
7742000 | |
| CY2018Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3456000 | |
| us-gaap |
Interest Paid Net
InterestPaidNet
|
61000 | ||
| us-gaap |
Interest Paid Net
InterestPaidNet
|
109000 | ||
| us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
-43000 | ||
| us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | ||
| us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
0 | ||
| us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
176000 | ||
| us-gaap |
Transfer To Other Real Estate
TransferToOtherRealEstate
|
371000 | ||
| us-gaap |
Transfer To Other Real Estate
TransferToOtherRealEstate
|
0 | ||
| ssy |
Right Of Use Asset Obtained In Exchange For Lease Liability
RightOfUseAssetObtainedInExchangeForLeaseLiability
|
1448000 | ||
| ssy |
Right Of Use Asset Obtained In Exchange For Lease Liability
RightOfUseAssetObtainedInExchangeForLeaseLiability
|
0 | ||
| us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 2. – Business Operations</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SunLink Health Systems, Inc., through subsidiaries, owns businesses which are providers of healthcare services in certain markets in the United States. SunLink’s subsidiaries’ businesses are composed of two business segments:</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Healthcare Services</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">•</font></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">A subsidiary which owns and operates Trace Regional Hospital and Floy Dyer Nursing Home (“Trace”), an 84 licensed-bed acute care hospital, located in Houston, Mississippi, which includes an 18-bed geriatric psychology unit (“GPU”), and a 66-bed nursing home. This facility focuses primarily on senior healthcare services.</font>   </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">•</font></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">A subsidiary, SunLink Health Systems Technology (SHS Technology), based in Atlanta, Georgia, which provides information technology (IT) services to outside customers and to SunLink subsidiaries.</font></p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">•</font></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Symbol;"><font style="font-size:10pt;font-family:'Times New Roman'">A</font><font style="font-size:10pt;font-family:'Times New Roman'"> </font></font><font style="font-family:Times New Roman;">subsidiary which owns approximately five (5) acres of unimproved land in Houston, Mississippi.</font> </p></td></tr></table></div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Pharmacy</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Pharmacy segment is composed of four operational areas which are conducted primarily in rural markets in Louisiana:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">•</font></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">Retail pharmacy products and services, provided by a retail pharmacy. </font></p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">•</font></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">Institutional pharmacy services consisting of the provision of specialty and non-specialty pharmaceutical and biological products to institutional clients or to patients in institutional settings, such as nursing homes, assisted living facilities, behavioral and specialty hospitals, hospice, and correctional facilities.</font></p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">•</font><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-family:Times New Roman;">Non-institutional pharmacy services consisting of the provision of specialty and non-specialty pharmaceutical and biological products to clients or patients in non-institutional settings including private residential homes. </font></p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td valign="top" style="width:4.25%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10pt;font-family:'Times New Roman'">•</font><font style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><font style="font-size:10pt;font-family:'Times New Roman'"> </font><font style="font-family:Times New Roman;">Durable medical equipment products and services (“DME”), consisting primarily of the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care.</font></p></td></tr></table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SunLink subsidiaries have conducted the Healthcare Services business since 2001 and the Pharmacy operations since 2008. Our Pharmacy segment currently is operated through Carmichael’s Cashway Pharmacy, Inc. (“Carmichael”), a subsidiary of our SunLink ScriptsRx, LLC subsidiary. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</p> | ||
| CY2019Q4 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-160000 | |
| CY2018Q4 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | |
| us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-160000 | ||
| us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
1995000 | ||
| us-gaap |
Supplies Expense
SuppliesExpense
|
612000 | ||
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
24457000 | ||
| CY2018Q4 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
982000 | |
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
685000 | ||
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
689000 | ||
| us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
2097000 | ||
| CY2018Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-134000 | |
| CY2018Q4 | us-gaap |
Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
|
452000 | |
| CY2018Q4 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
351000 | |
| us-gaap |
Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
|
193000 | ||
| us-gaap |
Supplies Expense
SuppliesExpense
|
653000 | ||
| us-gaap |
Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
|
454000 | ||
| CY2019Q4 | us-gaap |
Supplies Expense
SuppliesExpense
|
334000 | |
| us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
9758000 | ||
| us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
9294000 | ||
| CY2018Q4 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
4620000 | |
| CY2019Q4 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
350000 | |
| us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | ||
| CY2019Q4 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
203000 | |
| CY2019Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
203000 | |
| CY2018Q4 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
258000 | |
| us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
306000 | ||
| us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
303000 | ||
| CY2018Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
258000 | |
| CY2019Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
| CY2018Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
| CY2019Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
281000 | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | ||
| CY2019Q4 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
994000 | |
| CY2019Q4 | us-gaap |
Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
|
86000 | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | ||
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-575000 | ||
| us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
60000 | ||
| us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.01 | ||
| us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
-363000 | ||
| us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.07 | ||
| us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.01 | ||
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-575000 | ||
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
0 | ||
| us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-0.07 | ||
| CY2019Q4 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
147000 | |
| CY2018Q4 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
168000 | |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
60000 | ||
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-528000 | ||
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
0 | ||
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-303000 | ||
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6986000 | ||
| us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
-0.01 | ||
| us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
-0.01 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.08 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.08 | ||
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7309000 | ||
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7309000 | ||
| us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
-0.05 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | ||
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7012000 | ||
| CY2018Q4 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.04 | |
| CY2018Q4 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
0 | |
| CY2019Q4 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-42000 | |
| CY2018Q4 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
305000 | |
| CY2019Q4 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.03 | |
| CY2018Q4 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.04 | |
| CY2019Q4 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.03 | |
| CY2019Q4 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
-0.04 | |
| CY2018Q4 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0.01 | |
| CY2019Q4 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
-0.04 | |
| CY2018Q4 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0.01 | |
| us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
-0.05 | ||
| CY2019Q4 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
0 | |
| us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-528000 | ||
| CY2019Q4 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
-245000 | |
| CY2018Q4 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
47000 | |
| CY2019Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | |
| CY2018Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.04 | |
| CY2019Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
| CY2018Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.04 | |
| CY2019Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6986000 | |
| CY2018Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7271000 | |
| CY2019Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6992000 | |
| CY2018Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7278000 | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-443000 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
144000 | ||
| ssy |
Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
|
548000 | ||
| ssy |
Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
|
644000 | ||
| ssy |
Payments To Acquire Property Plant And Equipment Discontinuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuingOperations
|
0 | ||
| ssy |
Payments To Acquire Property Plant And Equipment Discontinuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuingOperations
|
50000 | ||
| CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4607000 | |
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3326000 | |
| CY2018Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
451000 | |
| CY2018Q4 | us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
0 | |
| CY2019Q4 | us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
0 | |
| us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
0 | ||
| us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
0 | ||
| us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
2 | ||
| CY2019Q4 | ssy |
Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
|
13000 | |
| CY2018Q4 | ssy |
Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
|
2078000 | |
| ssy |
Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
|
37000 | ||
| ssy |
Disposal Group Including Discontinued Operation Revenue Net Of Expenses
DisposalGroupIncludingDiscontinuedOperationRevenueNetOfExpenses
|
3930000 | ||
| CY2019Q4 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
-245000 | |
| CY2018Q4 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
47000 | |
| us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
-363000 | ||
| us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
-47000 | ||
| us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
3814 | ||
| ssy |
Share Repurchase Average Price Per Share Paid
ShareRepurchaseAveragePricePerSharePaid
|
1.17 | ||
| us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
359959 | ||
| ssy |
Share Repurchase Average Price Per Share Paid
ShareRepurchaseAveragePricePerSharePaid
|
1.03 | ||
| CY2019Q4 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
0 | |
| CY2018Q4 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
0 | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
27000 | ||
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1000 | ||
| CY2019Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
6275000 | |
| CY2019Q2 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
5230000 | |
| CY2019Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
648000 | |
| CY2019Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
515000 | |
| CY2019Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
462000 | |
| CY2019Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
332000 | |
| us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
477000 | ||
| CY2018Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
199000 | |
| CY2018Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
459000 | |
| CY2018Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
529000 | |
| us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
408000 | ||
| CY2019Q4 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
22000 | |
| CY2019Q2 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
195000 | |
| CY2019Q4 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | |
| CY2018Q4 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | |
| us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | ||
| us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | ||
| CY2019Q4 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | |
| CY2018Q4 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | |
| us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | ||
| us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | ||
| CY2019Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
8674000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
0 | |
| CY2019Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
19200000 | |
| ssy |
Net Operating Loss Carry Forwards Expire Period
NetOperatingLossCarryForwardsExpirePeriod
|
2023 through fiscal 2038 | ||
| CY2019Q4 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
143000 | |
| us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
290000 | ||
| CY2019Q4 | us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
4000 | |
| us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
15000 | ||
| CY2019Q4 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
9000 | |
| us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
18000 | ||
| CY2019Q4 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
2000 | |
| us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
5000 | ||
| CY2019Q4 | ssy |
Finance Lease Cost
FinanceLeaseCost
|
11000 | |
| ssy |
Finance Lease Cost
FinanceLeaseCost
|
23000 | ||
| CY2019Q4 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
203000 | |
| CY2018Q4 | us-gaap |
Assets
Assets
|
25726000 | |
| CY2019Q4 | us-gaap |
Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
|
20000 | |
| CY2019Q4 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
143000 | |
| ssy |
Number Of Taxing Authorities
NumberOfTaxingAuthorities
|
2 | ||
| CY2019Q4 | us-gaap |
Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority
IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
|
267000 | |
| CY2019Q4 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
297000 | |
| CY2018Q4 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
232000 | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
548000 | ||
| CY2019Q4 | us-gaap |
Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
|
us-gaap:PropertyPlantAndEquipmentNet | |
| CY2019Q4 | us-gaap |
Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
|
29000 | |
| CY2019Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
33000 | |
| CY2019Q4 | us-gaap |
Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
us-gaap:LongTermDebtCurrent | |
| CY2019Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
110000 | |
| CY2019Q4 | us-gaap |
Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
|
us-gaap:LongTermDebtNoncurrent | |
| CY2019Q4 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
150000 | |
| us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
289000 | ||
| CY2019Q4 | ssy |
Operating Cash Flows From Finance Lease
OperatingCashFlowsFromFinanceLease
|
2000 | |
| ssy |
Operating Cash Flows From Finance Lease
OperatingCashFlowsFromFinanceLease
|
5000 | ||
| CY2019Q4 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
8000 | |
| us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
16000 | ||
| CY2019Q4 | us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
0 | |
| us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
0 | ||
| CY2019Q4 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
9000 | |
| us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
1448000 | ||
| CY2019Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y10M28D | |
| CY2019Q4 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y9M7D | |
| CY2019Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0654 | |
| CY2019Q4 | us-gaap |
Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
|
0.0553 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
506000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
352000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
146000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
103000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
222000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
1329000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
133000 | |
| CY2019Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1196000 | |
| CY2019Q4 | us-gaap |
Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
|
42000 | |
| CY2019Q4 | us-gaap |
Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
|
42000 | |
| CY2019Q4 | us-gaap |
Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
|
42000 | |
| CY2019Q4 | us-gaap |
Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
|
37000 | |
| CY2019Q4 | us-gaap |
Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
|
0 | |
| CY2019Q4 | us-gaap |
Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
|
163000 | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
644000 |
